nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—head and neck cancer—thyroid cancer	0.597	1	CtDrD
Fluorouracil—ABCC4—Sorafenib—thyroid cancer	0.0497	0.205	CbGbCtD
Fluorouracil—ABCG2—Vandetanib—thyroid cancer	0.0443	0.183	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—thyroid cancer	0.0395	0.163	CbGbCtD
Fluorouracil—ALB—Vandetanib—thyroid cancer	0.0306	0.126	CbGbCtD
Fluorouracil—ABCG2—Sorafenib—thyroid cancer	0.0267	0.11	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—thyroid cancer	0.0162	0.067	CbGbCtD
Fluorouracil—CYP2C8—Sorafenib—thyroid cancer	0.0142	0.0588	CbGbCtD
Fluorouracil—CYP1A2—Sorafenib—thyroid cancer	0.011	0.0455	CbGbCtD
Fluorouracil—CYP2C9—Sorafenib—thyroid cancer	0.00993	0.041	CbGbCtD
Fluorouracil—UPP2—head—thyroid cancer	0.00267	0.0831	CbGeAlD
Fluorouracil—UPP1—trachea—thyroid cancer	0.00198	0.0616	CbGeAlD
Fluorouracil—UMPS—thyroid gland—thyroid cancer	0.00171	0.0532	CbGeAlD
Fluorouracil—UPP1—thyroid gland—thyroid cancer	0.00156	0.0487	CbGeAlD
Fluorouracil—UMPS—head—thyroid cancer	0.00151	0.0472	CbGeAlD
Fluorouracil—MTHFR—neck—thyroid cancer	0.00145	0.0453	CbGeAlD
Fluorouracil—DPYD—thyroid gland—thyroid cancer	0.00127	0.0396	CbGeAlD
Fluorouracil—TYMP—saliva-secreting gland—thyroid cancer	0.00121	0.0376	CbGeAlD
Fluorouracil—PPAT—thyroid gland—thyroid cancer	0.0011	0.0343	CbGeAlD
Fluorouracil—UMPS—lymph node—thyroid cancer	0.00106	0.033	CbGeAlD
Fluorouracil—UMPS—Afatinib—Vandetanib—thyroid cancer	0.00104	0.299	CbGdCrCtD
Fluorouracil—PPAT—head—thyroid cancer	0.000976	0.0304	CbGeAlD
Fluorouracil—UPP1—lymph node—thyroid cancer	0.000972	0.0303	CbGeAlD
Fluorouracil—TYMP—trachea—thyroid cancer	0.000931	0.029	CbGeAlD
Fluorouracil—DPYD—lymph node—thyroid cancer	0.000789	0.0246	CbGeAlD
Fluorouracil—TYMP—thyroid gland—thyroid cancer	0.000736	0.0229	CbGeAlD
Fluorouracil—SLC29A1—trachea—thyroid cancer	0.000716	0.0223	CbGeAlD
Fluorouracil—MTHFR—thyroid gland—thyroid cancer	0.000692	0.0216	CbGeAlD
Fluorouracil—PPAT—lymph node—thyroid cancer	0.000683	0.0213	CbGeAlD
Fluorouracil—TYMP—head—thyroid cancer	0.000653	0.0203	CbGeAlD
Fluorouracil—TYMS—thyroid gland—thyroid cancer	0.000632	0.0197	CbGeAlD
Fluorouracil—ABCC5—thyroid gland—thyroid cancer	0.000617	0.0192	CbGeAlD
Fluorouracil—MTHFR—head—thyroid cancer	0.000614	0.0191	CbGeAlD
Fluorouracil—SLC29A1—thyroid gland—thyroid cancer	0.000566	0.0176	CbGeAlD
Fluorouracil—TYMS—head—thyroid cancer	0.00056	0.0175	CbGeAlD
Fluorouracil—ABCC3—thyroid gland—thyroid cancer	0.000518	0.0161	CbGeAlD
Fluorouracil—SLC29A1—head—thyroid cancer	0.000502	0.0157	CbGeAlD
Fluorouracil—ABCG2—saliva-secreting gland—thyroid cancer	0.000495	0.0154	CbGeAlD
Fluorouracil—ABCC3—head—thyroid cancer	0.00046	0.0143	CbGeAlD
Fluorouracil—TYMP—lymph node—thyroid cancer	0.000457	0.0142	CbGeAlD
Fluorouracil—MTHFR—lymph node—thyroid cancer	0.00043	0.0134	CbGeAlD
Fluorouracil—ABCC4—thyroid gland—thyroid cancer	0.000428	0.0133	CbGeAlD
Fluorouracil—TYMS—Erlotinib—Vandetanib—thyroid cancer	0.000396	0.114	CbGdCrCtD
Fluorouracil—TYMS—lymph node—thyroid cancer	0.000392	0.0122	CbGeAlD
Fluorouracil—ABCC5—lymph node—thyroid cancer	0.000383	0.0119	CbGeAlD
Fluorouracil—ABCC4—head—thyroid cancer	0.000379	0.0118	CbGeAlD
Fluorouracil—Lacrimation—Epirubicin—thyroid cancer	0.000369	0.00471	CcSEcCtD
Fluorouracil—Dysphagia—Sorafenib—thyroid cancer	0.000368	0.0047	CcSEcCtD
Fluorouracil—Skin hyperpigmentation—Epirubicin—thyroid cancer	0.000365	0.00466	CcSEcCtD
Fluorouracil—Local reaction—Doxorubicin—thyroid cancer	0.000363	0.00463	CcSEcCtD
Fluorouracil—Febrile neutropenia—Epirubicin—thyroid cancer	0.000361	0.00461	CcSEcCtD
Fluorouracil—Vision blurred—Vandetanib—thyroid cancer	0.000359	0.00458	CcSEcCtD
Fluorouracil—SLC29A1—lymph node—thyroid cancer	0.000352	0.011	CbGeAlD
Fluorouracil—Lacrimation—Doxorubicin—thyroid cancer	0.000341	0.00436	CcSEcCtD
Fluorouracil—Skin hyperpigmentation—Doxorubicin—thyroid cancer	0.000338	0.00431	CcSEcCtD
Fluorouracil—Nail disorder—Epirubicin—thyroid cancer	0.000335	0.00427	CcSEcCtD
Fluorouracil—Febrile neutropenia—Doxorubicin—thyroid cancer	0.000334	0.00426	CcSEcCtD
Fluorouracil—Pneumonia—Sorafenib—thyroid cancer	0.00033	0.00422	CcSEcCtD
Fluorouracil—Convulsion—Vandetanib—thyroid cancer	0.00033	0.00421	CcSEcCtD
Fluorouracil—Infestation—Sorafenib—thyroid cancer	0.000328	0.00419	CcSEcCtD
Fluorouracil—Infestation NOS—Sorafenib—thyroid cancer	0.000328	0.00419	CcSEcCtD
Fluorouracil—Chest pain—Vandetanib—thyroid cancer	0.000324	0.00414	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000324	0.00413	CcSEcCtD
Fluorouracil—Myocardial infarction—Sorafenib—thyroid cancer	0.000322	0.00411	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000322	0.00411	CcSEcCtD
Fluorouracil—ABCC3—lymph node—thyroid cancer	0.000322	0.01	CbGeAlD
Fluorouracil—Stomatitis—Sorafenib—thyroid cancer	0.00032	0.00409	CcSEcCtD
Fluorouracil—Oedema—Vandetanib—thyroid cancer	0.000311	0.00397	CcSEcCtD
Fluorouracil—Epistaxis—Sorafenib—thyroid cancer	0.00031	0.00396	CcSEcCtD
Fluorouracil—Nail disorder—Doxorubicin—thyroid cancer	0.00031	0.00395	CcSEcCtD
Fluorouracil—Infection—Vandetanib—thyroid cancer	0.000308	0.00394	CcSEcCtD
Fluorouracil—Nervous system disorder—Vandetanib—thyroid cancer	0.000305	0.00389	CcSEcCtD
Fluorouracil—Thrombocytopenia—Vandetanib—thyroid cancer	0.000304	0.00388	CcSEcCtD
Fluorouracil—Nystagmus—Epirubicin—thyroid cancer	0.000304	0.00388	CcSEcCtD
Fluorouracil—ABCG2—thyroid gland—thyroid cancer	0.000302	0.0094	CbGeAlD
Fluorouracil—Blister—Epirubicin—thyroid cancer	0.000301	0.00384	CcSEcCtD
Fluorouracil—Haemoglobin—Sorafenib—thyroid cancer	0.000296	0.00378	CcSEcCtD
Fluorouracil—Haemorrhage—Sorafenib—thyroid cancer	0.000295	0.00377	CcSEcCtD
Fluorouracil—CYP1A2—thyroid gland—thyroid cancer	0.000291	0.00905	CbGeAlD
Fluorouracil—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000283	0.00361	CcSEcCtD
Fluorouracil—Nystagmus—Doxorubicin—thyroid cancer	0.000281	0.00359	CcSEcCtD
Fluorouracil—Insomnia—Vandetanib—thyroid cancer	0.000281	0.00359	CcSEcCtD
Fluorouracil—Paraesthesia—Vandetanib—thyroid cancer	0.000279	0.00356	CcSEcCtD
Fluorouracil—Blister—Doxorubicin—thyroid cancer	0.000279	0.00356	CcSEcCtD
Fluorouracil—Dyspnoea—Vandetanib—thyroid cancer	0.000277	0.00354	CcSEcCtD
Fluorouracil—Necrosis—Epirubicin—thyroid cancer	0.000276	0.00353	CcSEcCtD
Fluorouracil—ALB—lymph node—thyroid cancer	0.000274	0.00855	CbGeAlD
Fluorouracil—Dyspepsia—Vandetanib—thyroid cancer	0.000273	0.00349	CcSEcCtD
Fluorouracil—Decreased appetite—Vandetanib—thyroid cancer	0.00027	0.00345	CcSEcCtD
Fluorouracil—UMPS—Idarubicin—Epirubicin—thyroid cancer	0.000269	0.0774	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—thyroid cancer	0.000269	0.0774	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—thyroid cancer	0.000269	0.0774	CbGdCrCtD
Fluorouracil—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000268	0.00342	CcSEcCtD
Fluorouracil—Stinging—Epirubicin—thyroid cancer	0.000268	0.00342	CcSEcCtD
Fluorouracil—ABCC4—lymph node—thyroid cancer	0.000266	0.00828	CbGeAlD
Fluorouracil—Pain—Vandetanib—thyroid cancer	0.000266	0.00339	CcSEcCtD
Fluorouracil—Arrhythmia—Sorafenib—thyroid cancer	0.000263	0.00336	CcSEcCtD
Fluorouracil—Alopecia—Sorafenib—thyroid cancer	0.000261	0.00333	CcSEcCtD
Fluorouracil—TYMS—Afatinib—Vandetanib—thyroid cancer	0.000259	0.0747	CbGdCrCtD
Fluorouracil—Erythema—Sorafenib—thyroid cancer	0.000257	0.00328	CcSEcCtD
Fluorouracil—Necrosis—Doxorubicin—thyroid cancer	0.000256	0.00327	CcSEcCtD
Fluorouracil—Extravasation—Epirubicin—thyroid cancer	0.000249	0.00318	CcSEcCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—thyroid cancer	0.000249	0.0717	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—thyroid cancer	0.000249	0.0717	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—thyroid cancer	0.000249	0.0717	CbGdCrCtD
Fluorouracil—Stinging—Doxorubicin—thyroid cancer	0.000248	0.00316	CcSEcCtD
Fluorouracil—Body temperature increased—Vandetanib—thyroid cancer	0.000245	0.00314	CcSEcCtD
Fluorouracil—Cellulitis—Epirubicin—thyroid cancer	0.000239	0.00305	CcSEcCtD
Fluorouracil—Anaemia—Sorafenib—thyroid cancer	0.000237	0.00303	CcSEcCtD
Fluorouracil—Lacrimation increased—Epirubicin—thyroid cancer	0.000235	0.00301	CcSEcCtD
Fluorouracil—Herpes simplex—Epirubicin—thyroid cancer	0.000235	0.00301	CcSEcCtD
Fluorouracil—Extravasation—Doxorubicin—thyroid cancer	0.00023	0.00294	CcSEcCtD
Fluorouracil—Leukopenia—Sorafenib—thyroid cancer	0.00023	0.00293	CcSEcCtD
Fluorouracil—Dysarthria—Epirubicin—thyroid cancer	0.000229	0.00293	CcSEcCtD
Fluorouracil—Ulcer—Epirubicin—thyroid cancer	0.000229	0.00293	CcSEcCtD
Fluorouracil—TYMS—Gefitinib—Vandetanib—thyroid cancer	0.000226	0.0653	CbGdCrCtD
Fluorouracil—Inflammation—Epirubicin—thyroid cancer	0.000224	0.00286	CcSEcCtD
Fluorouracil—Cellulitis—Doxorubicin—thyroid cancer	0.000221	0.00282	CcSEcCtD
Fluorouracil—Pruritus—Vandetanib—thyroid cancer	0.00022	0.00281	CcSEcCtD
Fluorouracil—Myalgia—Sorafenib—thyroid cancer	0.000218	0.00279	CcSEcCtD
Fluorouracil—Lacrimation increased—Doxorubicin—thyroid cancer	0.000218	0.00278	CcSEcCtD
Fluorouracil—Herpes simplex—Doxorubicin—thyroid cancer	0.000218	0.00278	CcSEcCtD
Fluorouracil—Dermatitis contact—Epirubicin—thyroid cancer	0.000214	0.00274	CcSEcCtD
Fluorouracil—Diarrhoea—Vandetanib—thyroid cancer	0.000212	0.00271	CcSEcCtD
Fluorouracil—Dysarthria—Doxorubicin—thyroid cancer	0.000212	0.00271	CcSEcCtD
Fluorouracil—Ulcer—Doxorubicin—thyroid cancer	0.000212	0.00271	CcSEcCtD
Fluorouracil—Anaphylactic shock—Sorafenib—thyroid cancer	0.000209	0.00268	CcSEcCtD
Fluorouracil—Infection—Sorafenib—thyroid cancer	0.000208	0.00266	CcSEcCtD
Fluorouracil—Inflammation—Doxorubicin—thyroid cancer	0.000207	0.00264	CcSEcCtD
Fluorouracil—Nervous system disorder—Sorafenib—thyroid cancer	0.000205	0.00262	CcSEcCtD
Fluorouracil—Dizziness—Vandetanib—thyroid cancer	0.000205	0.00262	CcSEcCtD
Fluorouracil—Thrombocytopenia—Sorafenib—thyroid cancer	0.000205	0.00262	CcSEcCtD
Fluorouracil—Anorexia—Sorafenib—thyroid cancer	0.0002	0.00255	CcSEcCtD
Fluorouracil—Dermatitis contact—Doxorubicin—thyroid cancer	0.000198	0.00253	CcSEcCtD
Fluorouracil—Coma—Epirubicin—thyroid cancer	0.000198	0.00253	CcSEcCtD
Fluorouracil—Oesophagitis—Epirubicin—thyroid cancer	0.000198	0.00253	CcSEcCtD
Fluorouracil—Vomiting—Vandetanib—thyroid cancer	0.000197	0.00252	CcSEcCtD
Fluorouracil—Rash maculo-papular—Epirubicin—thyroid cancer	0.000197	0.00252	CcSEcCtD
Fluorouracil—Rash—Vandetanib—thyroid cancer	0.000196	0.0025	CcSEcCtD
Fluorouracil—Dermatitis—Vandetanib—thyroid cancer	0.000196	0.0025	CcSEcCtD
Fluorouracil—Headache—Vandetanib—thyroid cancer	0.000195	0.00248	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000191	0.00244	CcSEcCtD
Fluorouracil—Sepsis—Epirubicin—thyroid cancer	0.000188	0.0024	CcSEcCtD
Fluorouracil—ABCG2—lymph node—thyroid cancer	0.000188	0.00584	CbGeAlD
Fluorouracil—Dyspnoea—Sorafenib—thyroid cancer	0.000187	0.00239	CcSEcCtD
Fluorouracil—Nausea—Vandetanib—thyroid cancer	0.000184	0.00236	CcSEcCtD
Fluorouracil—Dyspepsia—Sorafenib—thyroid cancer	0.000184	0.00235	CcSEcCtD
Fluorouracil—Oesophagitis—Doxorubicin—thyroid cancer	0.000183	0.00234	CcSEcCtD
Fluorouracil—Coma—Doxorubicin—thyroid cancer	0.000183	0.00234	CcSEcCtD
Fluorouracil—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000182	0.00233	CcSEcCtD
Fluorouracil—Decreased appetite—Sorafenib—thyroid cancer	0.000182	0.00233	CcSEcCtD
Fluorouracil—Thrombophlebitis—Epirubicin—thyroid cancer	0.000182	0.00232	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000181	0.00231	CcSEcCtD
Fluorouracil—Photosensitivity—Epirubicin—thyroid cancer	0.000179	0.00229	CcSEcCtD
Fluorouracil—Pain—Sorafenib—thyroid cancer	0.000179	0.00229	CcSEcCtD
Fluorouracil—Sepsis—Doxorubicin—thyroid cancer	0.000174	0.00223	CcSEcCtD
Fluorouracil—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000168	0.00215	CcSEcCtD
Fluorouracil—Urticaria—Sorafenib—thyroid cancer	0.000166	0.00213	CcSEcCtD
Fluorouracil—Photosensitivity—Doxorubicin—thyroid cancer	0.000166	0.00212	CcSEcCtD
Fluorouracil—Body temperature increased—Sorafenib—thyroid cancer	0.000166	0.00211	CcSEcCtD
Fluorouracil—Dermatitis bullous—Epirubicin—thyroid cancer	0.000165	0.0021	CcSEcCtD
Fluorouracil—Cardiac failure—Epirubicin—thyroid cancer	0.000161	0.00206	CcSEcCtD
Fluorouracil—Lethargy—Epirubicin—thyroid cancer	0.000161	0.00205	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000157	0.00201	CcSEcCtD
Fluorouracil—Osteoarthritis—Epirubicin—thyroid cancer	0.000157	0.00201	CcSEcCtD
Fluorouracil—Hypersensitivity—Sorafenib—thyroid cancer	0.000154	0.00197	CcSEcCtD
Fluorouracil—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000152	0.00195	CcSEcCtD
Fluorouracil—Cardiac arrest—Epirubicin—thyroid cancer	0.00015	0.00191	CcSEcCtD
Fluorouracil—Cardiac failure—Doxorubicin—thyroid cancer	0.000149	0.00191	CcSEcCtD
Fluorouracil—Lethargy—Doxorubicin—thyroid cancer	0.000149	0.0019	CcSEcCtD
Fluorouracil—Pruritus—Sorafenib—thyroid cancer	0.000148	0.00189	CcSEcCtD
Fluorouracil—Ataxia—Epirubicin—thyroid cancer	0.000148	0.00189	CcSEcCtD
Fluorouracil—Osteoarthritis—Doxorubicin—thyroid cancer	0.000146	0.00186	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000146	0.00186	CcSEcCtD
Fluorouracil—Dry skin—Epirubicin—thyroid cancer	0.000144	0.00184	CcSEcCtD
Fluorouracil—Diarrhoea—Sorafenib—thyroid cancer	0.000143	0.00183	CcSEcCtD
Fluorouracil—Nasopharyngitis—Epirubicin—thyroid cancer	0.000141	0.0018	CcSEcCtD
Fluorouracil—Muscular weakness—Epirubicin—thyroid cancer	0.000139	0.00177	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—thyroid cancer	0.000139	0.00177	CcSEcCtD
Fluorouracil—Dizziness—Sorafenib—thyroid cancer	0.000139	0.00177	CcSEcCtD
Fluorouracil—Ataxia—Doxorubicin—thyroid cancer	0.000137	0.00175	CcSEcCtD
Fluorouracil—Dysphagia—Epirubicin—thyroid cancer	0.000136	0.00174	CcSEcCtD
Fluorouracil—Eosinophilia—Epirubicin—thyroid cancer	0.000135	0.00172	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—thyroid cancer	0.000134	0.00171	CcSEcCtD
Fluorouracil—Vomiting—Sorafenib—thyroid cancer	0.000133	0.0017	CcSEcCtD
Fluorouracil—Angina pectoris—Epirubicin—thyroid cancer	0.000133	0.00169	CcSEcCtD
Fluorouracil—Rash—Sorafenib—thyroid cancer	0.000132	0.00169	CcSEcCtD
Fluorouracil—Dermatitis—Sorafenib—thyroid cancer	0.000132	0.00169	CcSEcCtD
Fluorouracil—Headache—Sorafenib—thyroid cancer	0.000131	0.00168	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00013	0.00166	CcSEcCtD
Fluorouracil—Pancytopenia—Epirubicin—thyroid cancer	0.000129	0.00165	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—thyroid cancer	0.000129	0.00164	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000127	0.00162	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—thyroid cancer	0.000126	0.00161	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—thyroid cancer	0.000125	0.00159	CcSEcCtD
Fluorouracil—Nausea—Sorafenib—thyroid cancer	0.000124	0.00159	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000124	0.00159	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—thyroid cancer	0.000123	0.00157	CcSEcCtD
Fluorouracil—Pneumonia—Epirubicin—thyroid cancer	0.000122	0.00156	CcSEcCtD
Fluorouracil—Infestation NOS—Epirubicin—thyroid cancer	0.000121	0.00155	CcSEcCtD
Fluorouracil—Infestation—Epirubicin—thyroid cancer	0.000121	0.00155	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—thyroid cancer	0.00012	0.00153	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000119	0.00152	CcSEcCtD
Fluorouracil—Stomatitis—Epirubicin—thyroid cancer	0.000118	0.00151	CcSEcCtD
Fluorouracil—Urinary tract infection—Epirubicin—thyroid cancer	0.000118	0.00151	CcSEcCtD
Fluorouracil—Conjunctivitis—Epirubicin—thyroid cancer	0.000118	0.00151	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000117	0.0015	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000115	0.00147	CcSEcCtD
Fluorouracil—Epistaxis—Epirubicin—thyroid cancer	0.000114	0.00146	CcSEcCtD
Fluorouracil—Sinusitis—Epirubicin—thyroid cancer	0.000114	0.00145	CcSEcCtD
Fluorouracil—Agranulocytosis—Epirubicin—thyroid cancer	0.000113	0.00145	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—thyroid cancer	0.000113	0.00144	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—thyroid cancer	0.000112	0.00143	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—thyroid cancer	0.000112	0.00143	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00011	0.00141	CcSEcCtD
Fluorouracil—Haemoglobin—Epirubicin—thyroid cancer	0.00011	0.0014	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—thyroid cancer	0.000109	0.0014	CcSEcCtD
Fluorouracil—Rhinitis—Epirubicin—thyroid cancer	0.000109	0.0014	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—thyroid cancer	0.000109	0.00139	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—thyroid cancer	0.000109	0.00139	CcSEcCtD
Fluorouracil—Haemorrhage—Epirubicin—thyroid cancer	0.000109	0.00139	CcSEcCtD
Fluorouracil—Hypoaesthesia—Epirubicin—thyroid cancer	0.000108	0.00138	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—thyroid cancer	0.000108	0.00138	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—thyroid cancer	0.000106	0.00135	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—thyroid cancer	0.000105	0.00135	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—thyroid cancer	0.000105	0.00134	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—thyroid cancer	0.000101	0.00129	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—thyroid cancer	0.000101	0.00129	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—thyroid cancer	0.000101	0.00129	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—thyroid cancer	0.0001	0.00128	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—thyroid cancer	0.0001	0.00128	CcSEcCtD
Fluorouracil—Arrhythmia—Epirubicin—thyroid cancer	9.73e-05	0.00124	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—thyroid cancer	9.63e-05	0.00123	CcSEcCtD
Fluorouracil—Erythema—Epirubicin—thyroid cancer	9.48e-05	0.00121	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—thyroid cancer	9.01e-05	0.00115	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—thyroid cancer	8.94e-05	0.00114	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—thyroid cancer	8.91e-05	0.00114	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—thyroid cancer	8.78e-05	0.00112	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—thyroid cancer	8.77e-05	0.00112	CcSEcCtD
Fluorouracil—Leukopenia—Epirubicin—thyroid cancer	8.49e-05	0.00108	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—thyroid cancer	8.27e-05	0.00106	CcSEcCtD
Fluorouracil—Convulsion—Epirubicin—thyroid cancer	8.22e-05	0.00105	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—thyroid cancer	8.11e-05	0.00104	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—thyroid cancer	8.07e-05	0.00103	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—thyroid cancer	8.07e-05	0.00103	CcSEcCtD
Fluorouracil—Discomfort—Epirubicin—thyroid cancer	7.98e-05	0.00102	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—thyroid cancer	7.86e-05	0.001	CcSEcCtD
Fluorouracil—Confusional state—Epirubicin—thyroid cancer	7.81e-05	0.000997	CcSEcCtD
Fluorouracil—Anaphylactic shock—Epirubicin—thyroid cancer	7.74e-05	0.000989	CcSEcCtD
Fluorouracil—Oedema—Epirubicin—thyroid cancer	7.74e-05	0.000989	CcSEcCtD
Fluorouracil—Infection—Epirubicin—thyroid cancer	7.69e-05	0.000982	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—thyroid cancer	7.6e-05	0.000971	CcSEcCtD
Fluorouracil—Nervous system disorder—Epirubicin—thyroid cancer	7.59e-05	0.00097	CcSEcCtD
Fluorouracil—Thrombocytopenia—Epirubicin—thyroid cancer	7.58e-05	0.000968	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—thyroid cancer	7.55e-05	0.000965	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—thyroid cancer	7.47e-05	0.000954	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—thyroid cancer	7.47e-05	0.000954	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—thyroid cancer	7.38e-05	0.000943	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—thyroid cancer	7.38e-05	0.000942	CcSEcCtD
Fluorouracil—Hypotension—Epirubicin—thyroid cancer	7.23e-05	0.000924	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—thyroid cancer	7.22e-05	0.000922	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—thyroid cancer	7.16e-05	0.000915	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—thyroid cancer	7.16e-05	0.000915	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—thyroid cancer	7.12e-05	0.000909	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—thyroid cancer	7.05e-05	0.000901	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—thyroid cancer	7.02e-05	0.000897	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—thyroid cancer	7.01e-05	0.000896	CcSEcCtD
Fluorouracil—Insomnia—Epirubicin—thyroid cancer	7e-05	0.000894	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—thyroid cancer	6.99e-05	0.000893	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—thyroid cancer	6.95e-05	0.000888	CcSEcCtD
Fluorouracil—Dyspnoea—Epirubicin—thyroid cancer	6.9e-05	0.000881	CcSEcCtD
Fluorouracil—Somnolence—Epirubicin—thyroid cancer	6.88e-05	0.000879	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—thyroid cancer	6.83e-05	0.000872	CcSEcCtD
Fluorouracil—Dyspepsia—Epirubicin—thyroid cancer	6.81e-05	0.00087	CcSEcCtD
Fluorouracil—Decreased appetite—Epirubicin—thyroid cancer	6.73e-05	0.000859	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—thyroid cancer	6.69e-05	0.000855	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Epirubicin—thyroid cancer	6.68e-05	0.000854	CcSEcCtD
Fluorouracil—Pain—Epirubicin—thyroid cancer	6.62e-05	0.000845	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	6.53e-05	0.000833	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—thyroid cancer	6.48e-05	0.000827	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—thyroid cancer	6.43e-05	0.000821	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—thyroid cancer	6.39e-05	0.000816	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—thyroid cancer	6.38e-05	0.000815	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—thyroid cancer	6.37e-05	0.000813	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—thyroid cancer	6.3e-05	0.000805	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—thyroid cancer	6.23e-05	0.000795	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	6.18e-05	0.00079	CcSEcCtD
Fluorouracil—Urticaria—Epirubicin—thyroid cancer	6.15e-05	0.000785	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—thyroid cancer	6.12e-05	0.000782	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—thyroid cancer	6.12e-05	0.000782	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—thyroid cancer	5.9e-05	0.000754	CcSEcCtD
Fluorouracil—Hypersensitivity—Epirubicin—thyroid cancer	5.7e-05	0.000728	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—thyroid cancer	5.69e-05	0.000727	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—thyroid cancer	5.66e-05	0.000723	CcSEcCtD
Fluorouracil—Pruritus—Epirubicin—thyroid cancer	5.48e-05	0.000699	CcSEcCtD
Fluorouracil—Diarrhoea—Epirubicin—thyroid cancer	5.3e-05	0.000676	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—thyroid cancer	5.28e-05	0.000674	CcSEcCtD
Fluorouracil—Dizziness—Epirubicin—thyroid cancer	5.12e-05	0.000654	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—thyroid cancer	5.07e-05	0.000647	CcSEcCtD
Fluorouracil—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.93e-05	0.00106	CbGpPWpGaD
Fluorouracil—Vomiting—Epirubicin—thyroid cancer	4.92e-05	0.000629	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—thyroid cancer	4.9e-05	0.000626	CcSEcCtD
Fluorouracil—UMPS—Metabolism—PPARG—thyroid cancer	4.89e-05	0.00105	CbGpPWpGaD
Fluorouracil—Rash—Epirubicin—thyroid cancer	4.88e-05	0.000623	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—thyroid cancer	4.88e-05	0.000623	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	4.86e-05	0.00104	CbGpPWpGaD
Fluorouracil—Headache—Epirubicin—thyroid cancer	4.85e-05	0.000619	CcSEcCtD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—TPR—thyroid cancer	4.8e-05	0.00103	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—CP—thyroid cancer	4.8e-05	0.00103	CbGpPWpGaD
Fluorouracil—Dizziness—Doxorubicin—thyroid cancer	4.74e-05	0.000605	CcSEcCtD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.73e-05	0.00102	CbGpPWpGaD
Fluorouracil—Nausea—Epirubicin—thyroid cancer	4.6e-05	0.000587	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle—CDK1—thyroid cancer	4.56e-05	0.00098	CbGpPWpGaD
Fluorouracil—Vomiting—Doxorubicin—thyroid cancer	4.55e-05	0.000582	CcSEcCtD
Fluorouracil—UPP2—Metabolism—PPARG—thyroid cancer	4.54e-05	0.000977	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PPARG—thyroid cancer	4.54e-05	0.000977	CbGpPWpGaD
Fluorouracil—Rash—Doxorubicin—thyroid cancer	4.52e-05	0.000577	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—thyroid cancer	4.51e-05	0.000576	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—thyroid cancer	4.49e-05	0.000573	CcSEcCtD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.46e-05	0.000959	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MINPP1—thyroid cancer	4.46e-05	0.000958	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TPR—thyroid cancer	4.45e-05	0.000957	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.39e-05	0.000943	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PRKAR1A—thyroid cancer	4.38e-05	0.000942	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.36e-05	0.000937	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	4.28e-05	0.00092	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	4.28e-05	0.00092	CbGpPWpGaD
Fluorouracil—Nausea—Doxorubicin—thyroid cancer	4.25e-05	0.000543	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.24e-05	0.00091	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—SLC5A5—thyroid cancer	4.23e-05	0.000909	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MEN1—thyroid cancer	4.19e-05	0.0009	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—HPGD—thyroid cancer	4.17e-05	0.000896	CbGpPWpGaD
Fluorouracil—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	4.09e-05	0.000879	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—PTEN—thyroid cancer	4.07e-05	0.000874	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MINPP1—thyroid cancer	4.05e-05	0.000871	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4e-05	0.000861	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.98e-05	0.000856	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TPR—thyroid cancer	3.88e-05	0.000833	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—PTGS2—thyroid cancer	3.84e-05	0.000827	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.82e-05	0.000822	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PRKAR1A—thyroid cancer	3.81e-05	0.00082	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—NDUFA13—thyroid cancer	3.79e-05	0.000815	CbGpPWpGaD
Fluorouracil—CYP2C8—Biological oxidations—RXRA—thyroid cancer	3.77e-05	0.000809	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.75e-05	0.000806	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	3.74e-05	0.000803	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—TPR—thyroid cancer	3.73e-05	0.000801	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PRKAR1A—thyroid cancer	3.67e-05	0.000789	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MEN1—thyroid cancer	3.64e-05	0.000783	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IFNA2—thyroid cancer	3.62e-05	0.000777	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.6e-05	0.000773	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PTGS2—thyroid cancer	3.57e-05	0.000768	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PTGS2—thyroid cancer	3.57e-05	0.000768	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CHST14—thyroid cancer	3.56e-05	0.000766	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—RXRA—thyroid cancer	3.55e-05	0.000764	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	3.52e-05	0.000757	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	3.52e-05	0.000757	CbGpPWpGaD
Fluorouracil—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	3.49e-05	0.000751	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.47e-05	0.000745	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—NDUFA13—thyroid cancer	3.44e-05	0.00074	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.38e-05	0.000726	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—PTEN—thyroid cancer	3.35e-05	0.000721	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CALCA—thyroid cancer	3.33e-05	0.000716	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TERT—thyroid cancer	3.29e-05	0.000706	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.26e-05	0.000701	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.26e-05	0.0007	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.25e-05	0.000699	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—TPR—thyroid cancer	3.25e-05	0.000698	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CHST14—thyroid cancer	3.24e-05	0.000696	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.21e-05	0.000691	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	3.2e-05	0.000688	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PRKAR1A—thyroid cancer	3.19e-05	0.000686	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	3.18e-05	0.000683	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PPARG—thyroid cancer	3.15e-05	0.000677	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PPARG—thyroid cancer	3.15e-05	0.000677	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PTEN—thyroid cancer	3.12e-05	0.00067	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PTEN—thyroid cancer	3.12e-05	0.00067	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—RXRA—thyroid cancer	3.06e-05	0.000659	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.02e-05	0.000649	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CDK1—thyroid cancer	3.02e-05	0.000648	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	2.91e-05	0.000625	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CALCA—thyroid cancer	2.9e-05	0.000624	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—TPR—thyroid cancer	2.89e-05	0.000621	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.89e-05	0.000621	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—HPGD—thyroid cancer	2.87e-05	0.000618	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PRKAR1A—thyroid cancer	2.84e-05	0.000611	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—SLC5A5—thyroid cancer	2.79e-05	0.0006	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.78e-05	0.000598	CbGpPWpGaD
Fluorouracil—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	2.78e-05	0.000598	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—thyroid cancer	2.77e-05	0.000596	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MINPP1—thyroid cancer	2.77e-05	0.000595	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MINPP1—thyroid cancer	2.75e-05	0.000591	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.64e-05	0.000567	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDK1—thyroid cancer	2.63e-05	0.000565	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—RXRA—thyroid cancer	2.62e-05	0.000563	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—HPGD—thyroid cancer	2.61e-05	0.000561	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	2.5e-05	0.000538	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PTGS2—thyroid cancer	2.48e-05	0.000533	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PTGS2—thyroid cancer	2.48e-05	0.000533	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PRKAR1A—thyroid cancer	2.47e-05	0.000531	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.44e-05	0.000525	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—SLC5A5—thyroid cancer	2.43e-05	0.000522	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NRG1—thyroid cancer	2.42e-05	0.000521	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—TPR—thyroid cancer	2.39e-05	0.000514	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—thyroid cancer	2.38e-05	0.000512	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PRKAR1A—thyroid cancer	2.35e-05	0.000506	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NDUFA13—thyroid cancer	2.35e-05	0.000506	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—RXRA—thyroid cancer	2.34e-05	0.000504	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NDUFA13—thyroid cancer	2.34e-05	0.000503	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MINPP1—thyroid cancer	2.25e-05	0.000484	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PPARG—thyroid cancer	2.24e-05	0.000482	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.22e-05	0.000476	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CHST14—thyroid cancer	2.21e-05	0.000475	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CHST14—thyroid cancer	2.2e-05	0.000473	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TERT—thyroid cancer	2.17e-05	0.000467	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	2.17e-05	0.000467	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	2.17e-05	0.000467	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—SLC5A5—thyroid cancer	2.16e-05	0.000465	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PTEN—thyroid cancer	2.16e-05	0.000464	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PTEN—thyroid cancer	2.16e-05	0.000464	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.14e-05	0.00046	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.13e-05	0.000459	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	2.13e-05	0.000457	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CCND1—thyroid cancer	2.12e-05	0.000457	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRG1—thyroid cancer	2.11e-05	0.000453	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HIF1A—thyroid cancer	2.08e-05	0.000447	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—RXRA—thyroid cancer	2.04e-05	0.000439	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—AKT1—thyroid cancer	1.93e-05	0.000415	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MINPP1—thyroid cancer	1.92e-05	0.000414	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NDUFA13—thyroid cancer	1.91e-05	0.000412	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CCND1—thyroid cancer	1.9e-05	0.000408	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TERT—thyroid cancer	1.89e-05	0.000407	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—RXRA—thyroid cancer	1.82e-05	0.000391	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HIF1A—thyroid cancer	1.81e-05	0.000389	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CHST14—thyroid cancer	1.8e-05	0.000387	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—AKT1—thyroid cancer	1.8e-05	0.000386	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—AKT1—thyroid cancer	1.8e-05	0.000386	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—SLC5A5—thyroid cancer	1.79e-05	0.000385	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HPGD—thyroid cancer	1.78e-05	0.000383	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HPGD—thyroid cancer	1.77e-05	0.000381	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTGS2—thyroid cancer	1.77e-05	0.00038	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—BRAF—thyroid cancer	1.72e-05	0.00037	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.69e-05	0.000363	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.68e-05	0.000361	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—TPR—thyroid cancer	1.65e-05	0.000355	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IFNA2—thyroid cancer	1.64e-05	0.000352	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NDUFA13—thyroid cancer	1.64e-05	0.000352	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.63e-05	0.00035	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PRKAR1A—thyroid cancer	1.62e-05	0.000349	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTEN—thyroid cancer	1.54e-05	0.000331	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CHST14—thyroid cancer	1.54e-05	0.000331	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—RXRA—thyroid cancer	1.51e-05	0.000324	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—BRAF—thyroid cancer	1.5e-05	0.000322	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TPR—thyroid cancer	1.5e-05	0.000322	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PPARG—thyroid cancer	1.48e-05	0.000318	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	1.47e-05	0.000317	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.46e-05	0.000315	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HPGD—thyroid cancer	1.45e-05	0.000312	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.45e-05	0.000311	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.44e-05	0.000309	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTGS2—thyroid cancer	1.39e-05	0.000299	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.37e-05	0.000294	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NRAS—thyroid cancer	1.35e-05	0.00029	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PPARG—thyroid cancer	1.29e-05	0.000277	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—thyroid cancer	1.25e-05	0.000269	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AKT1—thyroid cancer	1.25e-05	0.000268	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AKT1—thyroid cancer	1.25e-05	0.000268	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HPGD—thyroid cancer	1.24e-05	0.000267	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC5A5—thyroid cancer	1.24e-05	0.000266	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTEN—thyroid cancer	1.21e-05	0.000261	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTGS2—thyroid cancer	1.21e-05	0.00026	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.18e-05	0.000253	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTGS2—thyroid cancer	1.16e-05	0.00025	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—thyroid cancer	1.16e-05	0.00025	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PPARG—thyroid cancer	1.15e-05	0.000247	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC5A5—thyroid cancer	1.12e-05	0.000241	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NRAS—thyroid cancer	1.08e-05	0.000233	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTEN—thyroid cancer	1.06e-05	0.000227	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—RXRA—thyroid cancer	1.04e-05	0.000223	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—thyroid cancer	1.03e-05	0.000222	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TPR—thyroid cancer	1.02e-05	0.00022	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TPR—thyroid cancer	1.02e-05	0.000219	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTEN—thyroid cancer	1.02e-05	0.000218	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—thyroid cancer	1.01e-05	0.000218	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.01e-05	0.000217	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.01e-05	0.000216	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PRKAR1A—thyroid cancer	1e-05	0.000215	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—thyroid cancer	9.87e-06	0.000212	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PPARG—thyroid cancer	9.5e-06	0.000204	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—RXRA—thyroid cancer	9.43e-06	0.000203	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRAS—thyroid cancer	9.42e-06	0.000203	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—thyroid cancer	9.31e-06	0.0002	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.13e-06	0.000196	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.08e-06	0.000195	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—thyroid cancer	9.03e-06	0.000194	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—thyroid cancer	8.87e-06	0.000191	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTEN—thyroid cancer	8.84e-06	0.00019	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—thyroid cancer	8.71e-06	0.000187	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TPR—thyroid cancer	8.33e-06	0.000179	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	8.2e-06	0.000176	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—thyroid cancer	8.11e-06	0.000174	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—thyroid cancer	7.92e-06	0.00017	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—thyroid cancer	7.88e-06	0.000169	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC5A5—thyroid cancer	7.66e-06	0.000165	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	7.65e-06	0.000164	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC5A5—thyroid cancer	7.62e-06	0.000164	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—thyroid cancer	7.48e-06	0.000161	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.43e-06	0.00016	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.18e-06	0.000154	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.14e-06	0.000154	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TPR—thyroid cancer	7.12e-06	0.000153	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	7.01e-06	0.000151	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—thyroid cancer	6.99e-06	0.00015	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—thyroid cancer	6.89e-06	0.000148	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARG—thyroid cancer	6.55e-06	0.000141	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—thyroid cancer	6.52e-06	0.00014	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—RXRA—thyroid cancer	6.44e-06	0.000138	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—RXRA—thyroid cancer	6.4e-06	0.000138	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.35e-06	0.000136	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.26e-06	0.000135	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC5A5—thyroid cancer	6.24e-06	0.000134	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.23e-06	0.000134	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—thyroid cancer	6.1e-06	0.000131	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—thyroid cancer	6.09e-06	0.000131	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARG—thyroid cancer	5.95e-06	0.000128	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—thyroid cancer	5.85e-06	0.000126	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.85e-06	0.000126	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC5A5—thyroid cancer	5.33e-06	0.000115	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—thyroid cancer	5.25e-06	0.000113	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—RXRA—thyroid cancer	5.24e-06	0.000113	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—thyroid cancer	5.15e-06	0.000111	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.1e-06	0.00011	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—thyroid cancer	5.1e-06	0.00011	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.99e-06	0.000107	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—thyroid cancer	4.68e-06	0.000101	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—thyroid cancer	4.67e-06	0.0001	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—thyroid cancer	4.54e-06	9.76e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—thyroid cancer	4.49e-06	9.66e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—RXRA—thyroid cancer	4.48e-06	9.63e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—thyroid cancer	4.46e-06	9.6e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.36e-06	9.36e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—thyroid cancer	4.08e-06	8.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARG—thyroid cancer	4.07e-06	8.74e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARG—thyroid cancer	4.04e-06	8.69e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—thyroid cancer	3.94e-06	8.48e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—thyroid cancer	3.76e-06	8.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARG—thyroid cancer	3.31e-06	7.11e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—thyroid cancer	3.2e-06	6.88e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—thyroid cancer	3.18e-06	6.84e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARG—thyroid cancer	2.83e-06	6.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—thyroid cancer	2.79e-06	6e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—thyroid cancer	2.77e-06	5.96e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.6e-06	5.6e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—thyroid cancer	2.59e-06	5.57e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—thyroid cancer	2.35e-06	5.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—thyroid cancer	2.27e-06	4.88e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.22e-06	4.78e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—thyroid cancer	1.94e-06	4.17e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—thyroid cancer	1.61e-06	3.46e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—thyroid cancer	1.6e-06	3.44e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—thyroid cancer	1.31e-06	2.81e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—thyroid cancer	1.12e-06	2.4e-05	CbGpPWpGaD
